BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12545999)

  • 1. Managing uncontrolled hemorrhage in trauma and surgery: a novel and promising approach.
    Hardy JF
    Can J Anaesth; 2002 Dec; 49(10):S4-6. PubMed ID: 12545999
    [No Abstract]   [Full Text] [Related]  

  • 2. Preemptive use of recombinant activated factor VII: many questions but few answers.
    Samama CM
    Can J Anaesth; 2006 Apr; 53(4):336-8. PubMed ID: 16575029
    [No Abstract]   [Full Text] [Related]  

  • 3. The potential use of recombinant activated factor VII in trauma and surgery.
    Sapsford W
    Scand J Surg; 2004; 93(1):17-23. PubMed ID: 15116814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant activated factor VII and the anaesthetist.
    Welsby IJ; Monroe DM; Lawson JH; Hoffmann M
    Anaesthesia; 2005 Dec; 60(12):1203-12. PubMed ID: 16288618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant Factor VIIa in blunt pelvic trauma.
    Hurst T; Blanckley S; Forrest M
    Anaesthesia; 2005 Dec; 60(12):1244-5; author reply 1245. PubMed ID: 16288629
    [No Abstract]   [Full Text] [Related]  

  • 6. Recombinant activated factor VII: panacea or passing fad?
    Parker RI
    Pediatr Crit Care Med; 2005 May; 6(3):379-80. PubMed ID: 15880015
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful use of activated recombinant factor VII in traumatic liver injuries in children.
    Kulkarni R; Daneshmand A; Guertin S; Fath J; Atwal M; Melvin J; LaFrance S
    J Trauma; 2004 Jun; 56(6):1348-52. PubMed ID: 15211149
    [No Abstract]   [Full Text] [Related]  

  • 8. Recombinant factor VIIa and trauma: treatment that does not leave you in the cold.
    Levi M
    J Thromb Haemost; 2007 Feb; 5(2):242-3. PubMed ID: 17181827
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of recombinant activated factor VII in the control of haemorrhage following blunt pelvic trauma.
    Udy A; Vaghela M; Lawton G; Sigston P
    Anaesthesia; 2005 Jun; 60(6):613-6. PubMed ID: 15918835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant activated factor VII in cardiac surgery: a systematic review.
    Warren O; Mandal K; Hadjianastassiou V; Knowlton L; Panesar S; John K; Darzi A; Athanasiou T
    Ann Thorac Surg; 2007 Feb; 83(2):707-14. PubMed ID: 17258029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible role of recombinant activated factor VII (rFVIIa) in the control of hemorrhage associated with massive trauma.
    Martinowitz U; Kenet G; Lubetski A; Luboshitz J; Segal E
    Can J Anaesth; 2002 Dec; 49(10):S15-20. PubMed ID: 12546003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery.
    Manning BJ; Hynes N; Courtney DF; Sultan S
    Eur J Vasc Endovasc Surg; 2005 Nov; 30(5):525-7. PubMed ID: 16099693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of recombinant activated factor VII in securing haemostatic failure in gun shot trauma.
    Shamsi T; Tufail M; Aftab M; Ansari S
    J Pak Med Assoc; 2006 May; 56(5):238-41. PubMed ID: 16767955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Off-label use of recombinant factor VIIA concentrates after cardiac surgery.
    Despotis G; Avidan M; Lublin DM
    Ann Thorac Surg; 2005 Jul; 80(1):3-5. PubMed ID: 15975330
    [No Abstract]   [Full Text] [Related]  

  • 15. Intraoperative pediatric blood transfusion therapy: a review of common issues. Part II: transfusion therapy, special considerations, and reduction of allogenic blood transfusions.
    Barcelona SL; Thompson AA; Coté CJ
    Paediatr Anaesth; 2005 Oct; 15(10):814-30. PubMed ID: 16176309
    [No Abstract]   [Full Text] [Related]  

  • 16. Recombinant factor VIIa and the surgical patient.
    Scarpelini S; Rizoli S
    Curr Opin Crit Care; 2006 Aug; 12(4):351-6. PubMed ID: 16810047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant factor VIIa in the treatment of bleeding.
    Midathada MV; Mehta P; Waner M; Fink LM
    Am J Clin Pathol; 2004 Jan; 121(1):124-37. PubMed ID: 14750250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of recombinant factor VIIa as a rescue treatment for intractable bleeding following repeat aortic arch repair.
    Stratmann G; Russell IA; Merrick SH
    Ann Thorac Surg; 2003 Dec; 76(6):2094-7. PubMed ID: 14667657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of recombinant factor VIIa in a patient with essential thrombocythaemia with uncontrolled surgical bleeding.
    Cervera JS; Mena-Durán AV; Piqueras CS
    Thromb Haemost; 2005 Feb; 93(2):383-4. PubMed ID: 15711760
    [No Abstract]   [Full Text] [Related]  

  • 20. Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
    Brenner B; Wiis J
    Hematology; 2007 Feb; 12(1):55-62. PubMed ID: 17364994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.